 Connie Valdez
Concepts (107)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pharmacy | 2 | 2022 | 30 | 1.530 |
Why?
| | Students, Pharmacy | 5 | 2020 | 99 | 1.010 |
Why?
| | Education, Pharmacy | 4 | 2020 | 130 | 0.910 |
Why?
| | Pharmacy Service, Hospital | 2 | 2022 | 86 | 0.850 |
Why?
| | Prescription Drugs | 1 | 2022 | 113 | 0.730 |
Why?
| | Pharmacies | 1 | 2020 | 31 | 0.730 |
Why?
| | Insulin | 2 | 2020 | 2157 | 0.630 |
Why?
| | Insulin Detemir | 1 | 2016 | 8 | 0.560 |
Why?
| | Ibuprofen | 1 | 2016 | 76 | 0.550 |
Why?
| | Insulin Lispro | 1 | 2016 | 35 | 0.550 |
Why?
| | Nonprescription Drugs | 1 | 2016 | 67 | 0.540 |
Why?
| | Polypharmacy | 1 | 2016 | 75 | 0.540 |
Why?
| | Caloric Restriction | 1 | 2016 | 91 | 0.520 |
Why?
| | Dietary Proteins | 1 | 2016 | 131 | 0.510 |
Why?
| | Renal Insufficiency | 1 | 2016 | 150 | 0.490 |
Why?
| | Diabetes Mellitus, Type 2 | 4 | 2020 | 2159 | 0.490 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 301 | 0.470 |
Why?
| | Bariatric Surgery | 1 | 2016 | 166 | 0.460 |
Why?
| | Pharmacists | 3 | 2022 | 235 | 0.400 |
Why?
| | Hypoglycemic Agents | 3 | 2020 | 1031 | 0.380 |
Why?
| | Adipokines | 1 | 2009 | 43 | 0.350 |
Why?
| | Educational Measurement | 3 | 2016 | 289 | 0.330 |
Why?
| | Osteoporosis | 1 | 2009 | 226 | 0.280 |
Why?
| | Bone Density | 1 | 2009 | 447 | 0.270 |
Why?
| | Heptanoic Acids | 1 | 2005 | 62 | 0.260 |
Why?
| | Body Composition | 1 | 2009 | 644 | 0.260 |
Why?
| | Health Maintenance Organizations | 1 | 2005 | 96 | 0.260 |
Why?
| | Simvastatin | 1 | 2005 | 65 | 0.260 |
Why?
| | Hypolipidemic Agents | 1 | 2005 | 86 | 0.250 |
Why?
| | Self Concept | 1 | 2006 | 213 | 0.250 |
Why?
| | Hyperlipidemias | 1 | 2005 | 127 | 0.250 |
Why?
| | Pyrroles | 1 | 2005 | 188 | 0.240 |
Why?
| | Patient Compliance | 1 | 2005 | 532 | 0.200 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2009 | 1130 | 0.190 |
Why?
| | Ambulatory Care Facilities | 1 | 2022 | 216 | 0.180 |
Why?
| | United States | 4 | 2022 | 12488 | 0.170 |
Why?
| | Guatemala | 1 | 2020 | 296 | 0.170 |
Why?
| | Nephrology Nursing | 1 | 2016 | 5 | 0.150 |
Why?
| | Community Pharmacy Services | 2 | 2007 | 45 | 0.140 |
Why?
| | Colorado | 4 | 2020 | 4178 | 0.140 |
Why?
| | Humans | 15 | 2022 | 118251 | 0.140 |
Why?
| | Drug Administration Routes | 1 | 2016 | 42 | 0.140 |
Why?
| | Health Services for the Aged | 1 | 2016 | 71 | 0.140 |
Why?
| | Drug Interactions | 1 | 2016 | 351 | 0.130 |
Why?
| | Clinical Competence | 3 | 2016 | 950 | 0.110 |
Why?
| | Pharmaceutical Preparations | 1 | 2015 | 168 | 0.110 |
Why?
| | Diagnosis, Differential | 1 | 2016 | 1379 | 0.100 |
Why?
| | Patient-Centered Care | 1 | 2016 | 493 | 0.100 |
Why?
| | Primary Health Care | 2 | 2020 | 1539 | 0.100 |
Why?
| | Angiotensin II Type 1 Receptor Blockers | 1 | 2010 | 32 | 0.090 |
Why?
| | Adult | 3 | 2022 | 31324 | 0.090 |
Why?
| | Prescriptions | 1 | 2010 | 63 | 0.090 |
Why?
| | Resistin | 1 | 2009 | 13 | 0.090 |
Why?
| | Critical Illness | 1 | 2015 | 661 | 0.090 |
Why?
| | Biological Factors | 1 | 2009 | 41 | 0.090 |
Why?
| | Obesity | 2 | 2015 | 2715 | 0.080 |
Why?
| | Economics, Pharmaceutical | 1 | 2008 | 10 | 0.080 |
Why?
| | Retrospective Studies | 3 | 2020 | 12929 | 0.080 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2010 | 194 | 0.080 |
Why?
| | Absorptiometry, Photon | 1 | 2009 | 226 | 0.080 |
Why?
| | Hip Joint | 1 | 2009 | 144 | 0.080 |
Why?
| | Leptin | 1 | 2009 | 228 | 0.080 |
Why?
| | Costs and Cost Analysis | 1 | 2008 | 201 | 0.080 |
Why?
| | Adiponectin | 1 | 2009 | 224 | 0.080 |
Why?
| | Middle Aged | 4 | 2016 | 27510 | 0.080 |
Why?
| | Cross-Sectional Studies | 2 | 2009 | 4521 | 0.080 |
Why?
| | Lumbar Vertebrae | 1 | 2009 | 214 | 0.080 |
Why?
| | Aged, 80 and over | 2 | 2016 | 6541 | 0.070 |
Why?
| | Aspirin | 1 | 2010 | 334 | 0.070 |
Why?
| | Accreditation | 1 | 2007 | 87 | 0.070 |
Why?
| | Confidentiality | 1 | 2006 | 66 | 0.070 |
Why?
| | Preceptorship | 1 | 2006 | 63 | 0.070 |
Why?
| | Medical Audit | 1 | 2005 | 75 | 0.060 |
Why?
| | Pilot Projects | 1 | 2009 | 1405 | 0.060 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2009 | 1159 | 0.060 |
Why?
| | Female | 4 | 2016 | 61261 | 0.060 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2008 | 1237 | 0.060 |
Why?
| | Severity of Illness Index | 1 | 2009 | 2659 | 0.050 |
Why?
| | Aged | 3 | 2010 | 19594 | 0.050 |
Why?
| | Physician-Patient Relations | 1 | 2005 | 484 | 0.050 |
Why?
| | Surveys and Questionnaires | 2 | 2016 | 4684 | 0.050 |
Why?
| | Research Design | 1 | 2006 | 961 | 0.050 |
Why?
| | Vaccination | 1 | 2007 | 1218 | 0.040 |
Why?
| | Lung | 1 | 2009 | 3623 | 0.040 |
Why?
| | Schools, Pharmacy | 2 | 2007 | 52 | 0.040 |
Why?
| | Pharmacokinetics | 1 | 2015 | 27 | 0.030 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2010 | 3358 | 0.030 |
Why?
| | Male | 3 | 2010 | 57474 | 0.030 |
Why?
| | Information Dissemination | 1 | 2015 | 193 | 0.030 |
Why?
| | Drug Prescriptions | 1 | 2015 | 248 | 0.030 |
Why?
| | Decision Support Systems, Clinical | 1 | 2015 | 176 | 0.030 |
Why?
| | Communication | 1 | 2016 | 754 | 0.020 |
Why?
| | Body Weight | 1 | 2015 | 923 | 0.020 |
Why?
| | Curriculum | 1 | 2016 | 908 | 0.020 |
Why?
| | Medication Therapy Management | 1 | 2010 | 70 | 0.020 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2016 | 1183 | 0.020 |
Why?
| | Diabetes Complications | 1 | 2010 | 218 | 0.020 |
Why?
| | Animals | 1 | 2008 | 33152 | 0.020 |
Why?
| | Guideline Adherence | 1 | 2010 | 520 | 0.020 |
Why?
| | Immunization Programs | 1 | 2007 | 206 | 0.020 |
Why?
| | Adolescent | 2 | 2015 | 18364 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2015 | 5230 | 0.020 |
Why?
| | Infant | 1 | 2015 | 8254 | 0.010 |
Why?
| | Practice Patterns, Physicians' | 1 | 2010 | 1197 | 0.010 |
Why?
| | Child, Preschool | 1 | 2015 | 9448 | 0.010 |
Why?
| | Child | 1 | 2015 | 19033 | 0.010 |
Why?
| | Young Adult | 1 | 2010 | 10731 | 0.010 |
Why?
|
|
Valdez's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|